Abstract
BackgroundThe NORwegian Disease Modifying Anti-Rheumatic Drugs (NOR-DMARD) registry has since 2000 been registering DMARD use and response in five different Norwegian rheumatology departments (ref). Almost 5,000 biologic treatment courses in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have